Basit öğe kaydını göster

dc.contributor.authorAlkan, Ali
dc.contributor.authorKayis, Deniz
dc.contributor.authorCelik, Serkan Yasar
dc.contributor.authorUylas, Selcuk
dc.contributor.authorPektas, Suzan Demir
dc.contributor.authorTapan, Ozge Oral
dc.contributor.authorTanrıverdi, Özgür
dc.date.accessioned2020-11-20T14:39:51Z
dc.date.available2020-11-20T14:39:51Z
dc.date.issued2020
dc.identifier.issn1078-1552
dc.identifier.issn1477-092X
dc.identifier.urihttps://doi.org/10.1177/1078155219900782
dc.identifier.urihttps://hdl.handle.net/20.500.12809/594
dc.descriptionTurkkan, Gorkem/0000-0002-9084-2599en_US
dc.descriptionWOS: 000512255900001en_US
dc.descriptionPubMed ID: 32028840en_US
dc.description.abstractIntroduction Oral cavity malignancies constitute 30% of head and neck cancers. The most common distant metastatic sites of glottic carcinoma are usually lung, liver and bone. Although the cutaneous metastasis of head and cancers have been reported with an incidence of 0.7-2.4%, skin metastasis of glottic carcinoma is extremely rare. Case report A 69-year-old male patient was admitted to the emergency department with hemoptysis, dyspnea, weakness in lower extremities and difficulty in swallowing. There were subcutaneous lesions with a diameter of 2-5 cm in the scalp, posterior chest wall, nose and abdomen. In addition, there was an ulcerating, painful mass on the right lateral part of the tongue. The biopsy of lesions on tongue and skin revealed a glottic squamous cell carcinoma with cutaneous metastasis. Management and outcome: The patient was treated with cisplatin 50 mg/m(2) on day 1, cetuximab 500 mg/m(2) on day 1 and 5-fluorouracil 1000 mg/m(2) daily on days 1 and 2, repeated every two weeks. After the first cycle of chemotherapy, the lesions on the skin regressed and dysphagia improved. Discussion There are limited data about the incidence, diagnostic measures and treatment modalities of glottic cancer with cutaneous metastasis. Our case could provide an important experience to literature by its atypical presentation and treatment-sensitive nature.en_US
dc.item-language.isoengen_US
dc.publisherSage Publications Ltden_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCetuximaben_US
dc.subjectCutaneous Metastasisen_US
dc.subjectGlottic Canceren_US
dc.subjectHead and Necken_US
dc.subjectSkinen_US
dc.titleManagement of a glottic squamous cell carcinoma with cutaneous metastasisen_US
dc.item-typearticleen_US
dc.contributor.departmenten_US
dc.contributor.departmentTemp[Alkan, Ali; Uylas, Selcuk; Tanriverdi, Ozgur] Mugla Sitki Kocman Univ, Med Oncol, Sch Med, Mugla, Turkey -- [Kayis, Deniz] Mugla Sitki Kocman Univ, Internal Med, Sch Med, Mugla, Turkey -- [Celik, Serkan Yasar] Mugla Sitki Kocman Univ, Pathol, Sch Med, Mugla, Turkey -- [Pektas, Suzan Demir] Mugla Sitki Kocman Univ, Dermatol, Sch Med, Mugla, Turkey -- [Tapan, Ozge Oral; Genc, Sebahat] Mugla Sitki Kocman Univ, Chest Dis, Sch Med, Mugla, Turkey -- [Gokdogan, Ozan] Mugla Sitki Kocman Univ, Otorhinolaryngol, Sch Med, Mugla, Turkeyen_US
dc.identifier.doi10.1177/1078155219900782
dc.identifier.volume26en_US
dc.identifier.issue6en_US
dc.identifier.startpage1495en_US
dc.identifier.endpage1498en_US
dc.relation.journalJournal of Oncology Pharmacy Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster